Public health
fromIPWatchdog.com | Patents & Intellectual Property Law
2 months agoFDA Wants to Make Life Easier for Biosimilars
FDA draft guidance relaxes biosimilar testing requirements, allowing analytic and targeted human studies in place of comparative efficacy trials to speed cheaper biosimilars.